INSIGHTS ON CLINICAL TRIAL DESIGN

• Ensuring Compliance In Gene Therapy Trials: IRB And IBC Views

  Explore ethical and regulatory challenges in neurological gene therapy trials, with expert insights on IRB/IBC collaboration, consent protocols, and oversight for vulnerable populations.

• Why Benchmarking Inflammatory Models Matters: What Early Human Data Tells Us

  Benchmarking immune challenge models clarifies early pharmacodynamic signals, helping teams distinguish true target engagement from variability, prioritize endpoints, and make confident decisions.

• Simultaneous Submissions And Managing Multiple Regulatory Pathways

  Global regulators are increasingly aligned, creating new opportunities for sponsors to pursue near-simultaneous submissions across major markets

• Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays

  Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.

• Tips And Tricks For Developing Rare Cancer Clinical Trials

  2/6/2025

  Conducting clinical trials for rare cancers presents unique challenges, making a partnership with an experienced Oncology CRO crucial for overcoming hurdles and ensuring trial success.

• Control And Transparency: Solving Sponsors' Key Challenges In Study Launch

  9/10/2024

  Learn how SaaS technology can revolutionize clinical trial launches by improving transparency, increasing control, and streamlining efficiency.

• The Role Of FDA Initiatives In Early-Phase Oncology Trials

  5/15/2025

  Project FrontRunner represents a paradigm shift in oncology drug development, championing earlier-line studies to bring novel treatments to patients sooner.

• The Future Of Patient Recruitment: Leveraging RWD For Precision

  4/25/2025

  To combat the costly challenges of patient recruitment and keep trials on track, sponsors can leverage real-world data.

• Improving The eCOA Experience

  1/25/2026

  Discover how template-driven builds and reuse can slash eCOA timelines by 50% while solving the licensing and translation hurdles that delay First Patient In.